Icon plc Stock
There is an upward development for Icon plc compared to yesterday, with an increase of €2.06 (2.380%).
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Icon plc.
With a target price of 191 € there is potential for a 113.69% increase which would mean more than doubling the current price of 89.38 € for Icon plc.
Pros and Cons of Icon plc in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | 2.380% | 5.451% | -0.490% | -46.205% | -42.317% | -53.448% | - |
| Alkermes plc | 0.780% | 4.132% | -2.326% | -18.182% | 6.780% | 5.594% | 52.727% |
| Ligand Pharmaceuticals | 2.300% | -3.279% | 10.625% | 75.248% | 6.627% | 182.207% | 35.632% |
| United Therapeutics | 2.240% | 2.944% | 9.768% | 62.033% | 9.665% | 129.369% | 237.122% |
Comments
Icon (ICLR) was upgraded by BMO Capital Markets from "market perform" to "outperform". They now have a $130.00 price target on the stock, up from $100.00.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat